They object to the high cost of new medicinal products, and say that small changes to them should not lead to a proportional prolongation of licences.
Tādēļ Parlaments mudina Komisiju veidot izglītojošas programmas, kas vēršas pret homofobiju, neizpratni un nosodījumu.